Suzetrigine is the first selective NaV1.8 pain signal inhibitor approved for acute pain, offering a non-opioid alternative amid the opioid crisis. Clinical trials demonstrated significant efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results